Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
MIRA Pharmaceuticals Reports Promising SKNY-1 Data for Obesity Tracking
MIRA Pharmaceuticals shared new preclinical data for SKNY-1, an oral candidate demonstrating strong brain penetration and once-daily dosing potential.
UCLA Wins $7.49M CIRM Grant to Advance Novel Multiple Sclerosis Therapy
A UCLA research team led by Dr. Lili Yang secured a $7.49M CIRM grant to transition an engineered NKT cell-based immunotherapy for MS into clinical trials.
Breakthrough HIV Vaccine Candidate Shows Major Promise in Primate Study
An experimental HIV vaccine from LJI and Scripps Research successfully generated broadly neutralizing antibodies in primates, marking a historic milestone.
FDA Approves First Generic Xofluza for Single-Dose Influenza Treatment
The FDA has approved Norwich Pharmaceuticals' generic baloxavir marboxil (Xofluza) for acute uncomplicated influenza and postexposure prophylaxis.
Chronic Babesiosis Treatment: DSMB Backs Tafenoquine Clinical Trials
The DSMB recommends 60 Degrees Pharmaceuticals continue its Phase 2 B-FREE clinical trial of tafenoquine to treat persistent fatigue in chronic babesiosis.
Celea Therapeutics Secures $180M for Phase 3 IPF Clinical Trials Test
Celea Therapeutics secured $180 million for the Phase 3 SURPASS-IPF trial of deupirfenidone, a promising new treatment for idiopathic pulmonary fibrosis.
WHO Begins Clinical Trials For New Ebola Virus Treatments in DR Congo.
The WHO has launched clinical trials in DR Congo to evaluate MBP134 and remdesivir as potential treatments for the deadly Bundibugyo Ebola virus strain.
New Remote Blood Cancer Clinical Trials Launched for Guernsey Patients
Guernsey blood cancer patients can now join UK clinical trials remotely. A new initiative transports excess tissue and blood samples to advance cancer research.
Targeted Cancer Therapies: Ryvu Therapeutics Expands Oncology Pipeline
Polish biotech Ryvu Therapeutics advances its small-molecule targeted cancer therapies pipeline, targeting solid tumors and malignancies in clinical trials.
AI in Drug Discovery: AdAlta Expands Biotech Pipeline With Octopi Network
AdAlta partners with Oktopi to integrate advanced artificial intelligence into its drug development workflows, optimizing investment and licensing decisions.
Cytomegalovirus Vaccine Development: Evaxion Unveils EVX-V1 Preclinical
Evaxion will present new preclinical data at IHW 2026 for EVX-V1, a novel AI-designed cytomegalovirus vaccine candidate addressing critical unmet needs.
Global Clinical Trials Network: Allucent Unveils IGNITE for Rapid Setup
Contract research organization Allucent launches the IGNITE network, connecting sponsors with over 250 pre-qualified sites to accelerate clinical trials.
13
14
15
16
17
18
19
20
21